pharmaceutical market research conference

19 Years Of Redefining Marketing Strategies for Your Digital Roadmap

Future pharma 2024.

June 25 - 27, 2024

The Westin Copley Place, Boston, MA

Apply For A Free Pass!

A limited amount of free passes for senior marketing and commercial executives in pharma are available. if you are interested, please fill out your information here., the world’s leading pharma commercialization event.

Future Pharma brings together heads of brands, marketing, commercial, digital, and patient advocacy/engagement as the only conference designed to align strategies and provide insights on commercial success. The collaborative approach to our program ensures that the speakers and content highlight exactly what is going on across the industry while building your professional skills and network.

The pharma marketing and commercial world is changing fast and reaching patients and HCPs requires more understanding than ever before. By developing the right content to reach the right customer at the right time and equipping your teams with the necessary tools and insights, Future Pharma is designed in collaboration with industry leaders to give insight on shared hurdles.

Our Speakers.

Bold, Brave and Innovative – Only the Best at Future Pharma.

Jennifer Muszik

Commerical Learning, Leadership Development, Executive Leadership Alkermes

Bill Veltre

Pharma Marketing Expert

Gwen Hyland

Head of Commercial Excellence, Rare Disease Alexion

Denise Dalton

Vice President, Omnichannel Strategy Bristol Myers Squibb

Brian Peters

Johnny Dogun

Director, Omnichannel Marketing (Respiratory Biologics) AstraZeneca

Jonathan Miller

Head of Commercial Excellence Ipsen

Stephanie Loiseau

Head of Marketing SK Life Science

Field Vice President Vaccines GSK

Catherine Blanchette

Global Head of Digital Innovation & Partnerships Sanofi

Head of Digital & IT - US Immunology & Cardiovascular, Commercialization IT Bristol Myers Squibb

Shefali Shah

Global Vice President, Market Value and Commercial Effectiveness MindMaze

Find What You’ve Been Missing

Connecting the Most Senior Marketing and Commercial Leaders in Pharma

Our programs are designed for you by you. Speakers and attendees join us from across the industry to learn from leaders who want to share their journeys. You'll hear honest, unbiased views of where the industry is now and where it’s headed. The insights that they offer showcase the benefits of peer-to-peer learning which Future Pharma is proud to help foster.

Joining Personal and Non-Personal Strategies for Commercial Success

Deep connections are at the heart of what Future Pharma is about. We offer a curated agenda full of interactive sessions and dedicated networking opportunities that balance the most relevant marketing and commercial content so you can deliver a top-notch patient experience. Brimming with inspirational leaders, the latest trends, actionable strategies and valuable solutions, Future Pharma is the eyes and ears for pharma marketing and commercial leaders.

An Ideal Networking Experience

Interactivity is sewn into every fabric of the Future Pharma experience. Learn organically and meet faces of the industry in a variety of custom-built, interactive sessions. Plus, with an entire afternoon dedicated to pharma executives only (no vendors!), you’ll have conversations on your terms, develop relationships, and speak “off-the-record” with your peers.

Agenda at a Glance

Wednesday, june 26, keeping up with marketing and commercial trends.

• Opening Fireside Keynote: The State of Pharma Marketing and Commercialization Today
• Keynote Panel Discussion with Live Polling: The Digital Future: Strategies, Processes and Tools that will Change the Way We Operate
• Keynote Partner Presentation: More Than Just a Shiny Tool: Developing a Successfully Agile Martech Strategy
• Panel Discussion: Be Real – Getting Personalization and Authenticity Right on Social Media in the Age of Increased Privacy and Data Protection
• Keynote Fireside Chat: Setting Up Your Digital Journey for Success Across Multiple Channels at the Brand and Enterprise Levels
• Case Study: Knocking Face to Face HCP Engagement Out of the Park

Thursday, June 27

Refining strategies for success.

• Case Study: Developing Sound Strategies: Understanding Your Organization’s Dynamics to Create Value as a Leader
• Partner Keynote Presentation: How the Relationship with Advertising Agencies is Evolving in the Face of Tighter Budgets and Increased Technological Innovation
• Panel Discussion with Live Polling: Women in Pharma Leadership Forum
• Panel Discussion with Live Polling: The Importance of Equitable Access for Sustained Brand Success
• Panel Discussion: Fostering Innovation in Times of Change and Hiring for Future Success
• Mentorship Roundtables

Word On The Street

“This was the best conference I have attended. I liked the focus on sales and marketing along with it being senior executives. It made the conversations incredibly meaningful.”

Jay Graves VP, Sales ROCHE

Valuable content.

"The roundtable discussions were interesting, valuable, and very interactive….both to learn from others & share to get others' perspective."

Edward Stelmack Director, Head Commercial Data AstraZeneca

A welcoming community.

“The experience has been great, very informative. The best part was learning best practices from other countries. The networking was very good and not intimidating.”

Ed Sucre Lead Commercial Excellence Analyst Mylan

Growing a Greener Future.

Future Pharma is dedicated to creating a more sustainable world for this generation and future ones. By registering for the event, will automatically be donated to One Tree Planted on your behalf. Want to get involved?

One of a Kind Community

Senior marketing and sales leaders from 100 of the most exciting pharma companies!

The Future Pharma Audience Profile

Job Function

MUST-ATTEND EVENT

“I now consider PharmaForce THE event that my team and I should attend every year, and am joining the Advisory Board to help shape the program and improve on its successes”

Brian Peters VP, Marketing Medexus Pharma

Focused on current trends.

“Future Pharma is committed to identifying current trends, opportunities, and threats to the vitality and success of the pharma industry - and prioritizes these as topics for discussion.”

Deb Hussain Senior Director, Marketing LILLY USA

Intimate discussion.

“I liked the format of the discussion groups.  It allowed an opportunity to have a more intimate discussion with the speakers and get input from others.”

Lauren Merendino National Sales Director Genentech

Real reviews from real attendees, #futurepharma.

Who said conferences can't be fun? We’re known in the industry for awesome experiences you can’t get anywhere else. You’ll come as an attendee, and leave as part of a community.

Have a Wicked Good Time in Boston

The westin copley place.

June 25-27, 2024 10 Huntington Avenue Boston, MA, 02116 Website

Our Sponsors:

13th Annual Pharma Market Research Conference

• Newark Liberty International Airport Marriott
• Essex County
• United States
• View on a map
• Visit the website for this event
• Organiser: Pharma Market Research Conference
• Name: Ross F.
• Email: [email protected]
• Telephone: +12122287974

Add to calendar Add to Google Calendar Add to Outlook.com

The 13th Annual Pharma Market Research Conference (May 10-11, 2022, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 10+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.

You are leaving PharmiWeb.com

Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.

ABOUT THIRD PARTY LINKS ON OUR SITE

PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com.

PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.

Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely.

If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.

• [email protected]
• +1.212.228.7974

USA: FEBRUARY 2018, NJ

JUNE 12-13, 2024, SAN FRANCISCO

• Advisory Board
• Notable Keynotes
• Attendee Alumni
• Job Postings
• Registration

Powerful sessions in various formats (presentations, panels, and round tables) from expert speakers hitting groundbreaking territory and discussing what matters most.

Distinguished industry leaders who come prepared to actively engage and share the latest insights.

SPONSORS/EXHIBITORS

The world’s leading biotech and pharma companies that are pushing the industry to innovate and adapt.

• 11th Annual Pharma Market Research ...
• Artificial Intelligence: A Therapist’s New ...

• Issues 2020

11th Annual Pharma Market Research Conference

• Healthcare Industry

• by PM360 Staff March 7, 2020

The Pharma Market Research Conference (PMRC) powered up for its first 2020 event this past February, celebrating 11 years as one of the industry’s most attended and well-regarded events. This year’s program kick-started 2020 with more than 50 diverse sessions, including every hot topic and cutting-edge case study, and included the participation of more than 100 companies.

The impressive 2020 program agenda was led by two dynamic keynotes: One from Google (“Connected Health at the Speed of Life”) and one from BioLabs@NYULangone (“Innovation Trends in the New Decade”). That was just the start for the hundreds of attendees seeking the latest advancements and insights, since during the two-day program they were able to hear from more than 70 senior-level speakers. This included the popular Executive Boardroom panel, featuring industry veterans from Bayer, Bristol-Myers Squibb, Merck, Pfizer, and more.

Networking was also on the agenda, as attendees had ample opportunities to mingle in a collegial environment. PMRC’s Casino Night provided the perfect setting to relax and win, while still keeping things professionally rewarding.

The PMRC remains the best and largest industry assembly of market research executives in pharma, biotech, medical devices, and diagnostics for more than 10 years. Another PMRC event planned for 2020 is the 4 th Annual Bay Area Pharma Market Research Conference, being held June 16-17 at the Embassy Suites by Hilton San Francisco Airport. Then PMRC will return to New Jersey for the 12 th Annual Pharma Market Research Conference (February 3-4, 2021). For additional information, visit  www.pharmamarketresearchconference.com .

PM360 Staff

Artificial Intelligence: A Therapist’s New Assistant

Help Providers to Help Your Brand

Experts on call.

Bud Bilanich Success Coach

David Linetsky Point-of-Care Marketing

Paul Theisen Patient Acquisition

Brenda Snow Authentic Patient Voice

Liz Kane Impactful Strategy

Amy Giles Increasing Engagement

Frank Burrell Scientific Storytelling

Joey Cohen Medication Adherence

Daniel Sontupe Market Access

Pat Purcell Meeting Engagement

Stacey Gandler Brand Nourishment

Matthew Durham Omnidynamic Marketing

Suma Ramadas, PhD Medical Affairs

Matt Turner Patient Affordability

You May Also Like

• Social Media

Trendsetter: Up Close Interview with Rob Rebak, of Quality Health

Rob Rebak is Chairman and Chief Executive Officer of QualityHealth. He is a 20-year ...

• Digital Tactics
• Feature Articles
• January/February

Bots, Impersonators, and Account Takeovers, Oh My! Protecting Your Brand on Social Media

Anyone who has paid attention to politics in the past few years has seen ...

• Marketing Strategy

Two Key Questions About Data Analytics 2020

PM360 asked analytics experts about the impact of Google, Safari, and Firefox all phasing ...

Confirm Password

Remember Me

Forgotten Password?

Username or Email

Pharma Market Research Conference

• Aspiring MSL
• Clinical Research / Clinical Trials
• Digital & Tech
• Health Economics & Market Access
• Medical Information
• MSL/Scientific Communications
• Patient-focused
• Pharmacovigilance
• Regulatory Affairs
• Awards & Recognition

Conferences

The 15th Annual Pharma Market Research Conference (February 7-8, 2024, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.

The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.

This event wills suit medical affairs professionals with any level of interest/experience with market research.

Dynamic Global Events

8th Digital Strategy & Innovation for Medical Affairs

08:00, Wednesday, 5 Jun 2024 + 1 more

08:00, Thursday, 6 Jun 2024

PDA Asia Pacific

2024 PDA Cell and Gene Pharmaceutical Products Conference​

09:30, Wednesday, 10 Jul 2024 + 1 more

08:30, Thursday, 11 Jul 2024

Reuters Events – Pharma

Reuters Events: Pharma Japan 2024

09:00, Wednesday, 25 Sep 2024 + 1 more

09:00, Thursday, 26 Sep 2024

My Medical Affairs is a Swipe Health Platform

Feature an Event

Useful Resources

List Your Company

• Privacy Policy
• Terms of Service

Accept Cookies?

Privacy overview, you are attempting to log out of myma.

Do you really want to log out?

[email protected]

+1.212.228.7974

USA: SEPTEMBER 12-13 2017, PARSIPPANY, NJ

View Our Pharma Competitive Intelligence & Pharma Market Research Conferences:

EUROPE: April 16-17, 2024, Munich, Germany

USA: September 25-26, 2024, Newark, New Jersey

ASIA: Coming 2020

BAY AREA: June 12-13, 2024, South San Francisco, CA

USA: February 5-6, 2025, Newark, New Jersey

Pharma CI Conference PO Box 1295 New York, NY 10276

Bay Area Pharma Market Research Conference 2024

Pharma Market Research Conference

What is the Bay Area Pharma Market Research Conference 2024?

The Bay Area Pharma Market Research Conference (June 12-13, 2024, South San Francisco) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.

The event is unlike any other conference in the Bay Area. It’s immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.

The Pharma Market Research Conference is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years.

Where will the Bay Area Pharma Market Research Conference be held in 2024?

The Bay Area Pharma Market Research Conference will be held at Embassy Suites by Hilton San Francisco Airport (250 Gateway Boulevard).

The Bay Area Pharma Market Research Conference will be held on June 12-13, 2024.

To learn more and to register, click here .

Start Date: June 12

End Date: June 13

Organizer: Pharma Market Research Conference

Venue: In-person

Embassy Suites by Hilton San Francisco Airport 250 Gateway Boulevard San Francisco, CA 94080 United States

For more information and to register for the event, please go to the event's website:

More Upcoming Events

• Board Agency Members
• Classification Committee
• Data and Systems Committee
• Ethics Committee
• Forecasting Forum
• Learning and Development Committee
• Fieldwork Forum
• Devices and Diagnostics Group
• New Form Codes Committee
• President's Award
• Jack Hayhurst Award
• MR Excellence Awards
• Young Professionals Conference Grants
• Our History
• Join EPHMRA
• Agency Members List
• Industry Members List
• Member Orientation
• Suppliers Directory
• Past Events
• About Classification
• 2025 Provisional developments
• New Form Codes
• EPHMRA standards
• Code of Contact Enquiry Form
• Ethics Team
• Resource Hub
• Resource search
• Get in touch

EPHMRA Annual Conference: 2024

The 2024 Conference - super early bird conference registration will open in early November.  Register and save money by ensuring you have your places booked now.  In January higher registration prices will apply.

Join us on 25-27 June 2024 at the Leonardo Royal London St Paul's.

The conference hub is www.ephmraconference.org

Looking for training on Data Protection?

Data protection training.

Log into the web site - you can take the training as a member for free.

The aim of this online course is to enable delegates to understand the legislation and apply it to the research and research healthcare context.

The learning outcomes and objectives of this course:

• Understand how the EU GDPR is structured and learn the definitions, concepts and principles of the legislation;

• Learn how non-EU countries have adapted and applied the legislation, particularly those markets covered by the EPHMRA Code;

• Understand how GDPR and similar legislation applies when collecting data for healthcare research.

Ethics Support from EPHMRA

Log in to the EPHMRA web site and find in Resources - Ethics - a range of valuable support:

Consent Form templates - France, Germany, Italy, Spain UK

FMV - our members only - summary report on HCP FMV

Classification

Become a Member

Suppliers directory.

Join us for an informative webinar which will focus on giving our members some hints and tips about ‘Doing market research in Mexico’.

See the paper: Segmentation in the time of Omnichannel, at the 2024 EPHMRA Conference.

Join us at the 2024 EPHMRA Conference and hear about the paper... ‘Applying a ‘human’ approach to strategy development

• Sustainability
• R&D/Clinical Trials
• Executive Roundtable
• Sales & Marketing
• Executive Profiles
• Market Access
• Patient Engagement
• Supply Chain
• Industry Trends

US Pharma and Biotech Summit 2024: The View from Investors

Industry experts gather to discuss the current investor market and how the IRA may impact the industry in the coming years.

Soft Landing, Hard Problems Financial Times US Pharma and Biotech Summit 2024

After the post-Covid crash, investors are seeing promising trends in the pharma and biotech industry in 2024.

The following speakers presented a panel discussing the industry from an investors perspective at the Financial Times’ US Pharma and Biotech Summit 2024 in New York City: Harmeet Dhillon, head of public policy at GSK; Amit Sinha, chief investment officer at Goldman Sachs; Darius Lakdawalla, quintiles chair in pharmaceutical development at the University of Southern California; and Johanna Grossman, head of healthcare and US life sciences at the US Stock Exchange. Oliver Barnes, a US pharmaceutical and biotech correspondent for the Financial Times moderated the event.

The conversation focused on both the current state of the industry and where each of the speakers felt it might go in the coming year.

Grossman began by discussing how the pharma and biotech industries are performing fairling consistently with the US Stock Market. There have been strong IPOs and an increase in mergers and acquisitions.

“Looking at the buyers,” she said, “they're looking for those late stage and data driven stories. They’re looking for those companies that have a value inflection point in the near term. These companies seem more attractive, mostly because they tend to be a little bit more quote unquote, de risked, as an investment.”

Sinha shared a similarly positive outlook on the industry, saying that there are several areas he and other investors are excited about.

“Our point of view is that innovation in this space has never been better than it is right now,” he said. “You can look at cancer, inflammation, some of the things that are happening with cell therapy, and diseases like lupus. It's really remarkable. From a fundamental science perspective, we would argue it's never been better if you put on the mindset of an investor where we focus on private investing and so are a certain period for IPOs going public.”

All of the panelists agreed that there is a lot of uncertainty around the Inflation Reduction Act. Dhillon referred to it as a “market shaping act” and that it will take a decade to see how significant its impact is.

He explained, “If you if you dig a little bit deeper and think about new formulations and new indications, it definitely changes how we think about where we allocate money internally, and whether we pursue a new patient new formulation for a product that could be meaningful to a patient, but not necessarily is driven by financial incentives.”

Lakdawalla also discussed how the IRA might impact pricing trends and drug launches.

“It'll take probably five or 10 years to play out on the negotiation side,” he said, “which is really more price setting than it is negotiation. There is a lot of question about what CMS is going to do to set prices. And they've been pretty vague about how they're going to do that in order to preserve flexibility and discretion. In fact, I think it's clear that the guidance that they issued for this year's price saying they're not going to hold themselves to in future years. So even if you look at if you look at what happens in the fall, you're not going to get a lot of insight into what's going to happen in the following years. So that's part of the uncertainty. Then there's also a market level uncertainty, which is because of the inflation boundaries that, in some ways, probably pose the most pivotal risk for the industry. The question is, how is that going to be handled? So now there's asymmetric risk when you set your launch prices. If you set your launch price too low, there's not really a way out.”

US Pharma and Biotech Summit 2024: When FDA Needs to Regulate AI

Tala Fakhouri spoke at the conference about FDA’s approach to determining when it even needs to regulate the usage of AI in the pharma industry.

Novo Holdings Acquires Majority Share of Single Use Support to Expand Life Science Tools, Diagnostics Portfolio

Novo Holdings is expected to acquire 60% of Single Use Support, with the remaining shares being held by Danaher and the company founders.

AbbVie, Gilgamesh Pharmaceuticals Agree to Terms on a Collaboration to Develop Advanced Therapies for Psychiatric Disorders

The joint venture aims to address unmet needs in the treatment of mood and anxiety disorders through novel neuroplastogens.

Aardvark Therapeutics Completes $85 Million Oversubscribed Series C Round of Funding, Aiming to Advance ARD-101 for Hyperphagia in Patients with Prader-Willi Syndrome

Led by Decheng Capital, the successful round of funding also included participation from investors such as Cormorant Asset Management, Surveyor Capital, and the Foundation for Prader-Willi Research.

Seven Essential Attributes for Investing in Life Sciences

These factors provide investors with enough information to identify promising investment opportunities.

2 Commerce Drive Cranbury, NJ 08512

609-716-7777

Newsletters and Deep Dive digital magazine

Conference report: Reuters Pharma Europe

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.

Tune in to learn about the challenges of expanding access to advanced therapies, like cell and gene treatments, across Europe's diverse market, and how discrepancies in time to market between member states create headaches for manufacturers.

On the subject of equitable access, the trio also touch upon the need to address historical inequities in clinical research, the evolving role of digital tools in enhancing the patient experience, and calls from industry leaders to "rewire the management of disease" for the innovations ahead.

Plus, with the hype of previous years giving way to a clearer view of AI's disruptive potential, is it time to grieve, or can pharma companies successfully unite technology and humans to drive real innovation for patients? And what does all this have to do with row boats?

To find out more, you can listen to episode 124 of the  pharmaphorum podcast  using the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on  iTunes ,  Spotify ,  acast ,  Stitcher , and  Podbean .

Reuters Pharma Europe 2024

Overcoming challenges with maternal vaccine trials

Childhood vaccines have proven to be one of the most effective public health interventions to reduce infant and child mortality.

Reuters Pharma Europe 2024 – Peter Stenico

Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.

Innovation as Strategy: Enabling life sciences of the future

Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.

Chasing the holy grail of value-based healthcare

Patients, healthcare professionals, payers, and other stakeholders can have vastly different views on the value of a particular product, often resulting in a struggle between prioritising a

How doctors are interacting with content in 10 data trends

It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.

Patient Centricity to Integration: Enhancing Cancer Outcomes

We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.

3rd mRNA Process Development & Manufacturing Summit

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into

2nd mRNA Quality Control & Compliance Summit

The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

cell and gene therapies

Clinical research, digital tools, editor's picks, regeneron gene therapy restores hearing in deaf child, pfizer pauses dmd gene therapy trial after boy’s death, sanofi forges $1.2bn alliance with vaccines firm novavax, alphafold 3 takes structure predictions well beyond proteins, double apoe4 gene a 'distinct form' of early alzheimer’s.

Obesity drugs could bankrupt US healthcare, says Sanders

A report issued by the office of US Senator Bernie Sanders has claimed that the high prices being charged for new GLP-1 agonist-based obesity therapies like Novo Nordisk’s

Fixing clinical trial data management

It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.

We couldn’t find any results matching your search.

Please try using other words for your search or explore other sections of the website for relevant information.

We’re sorry, we are currently experiencing some issues, please try again later.

Our team is working diligently to resolve the issue. Thank you for your patience and understanding.

Market Activity

• Major Indexes

U.S. Major Indexes

Retail trading activity tracker.

What is Retail Trading Activity Tracker? This dataset tracks the daily buying and selling activity of retail investors at the ticker level.

• "% of Retail Activity” is the ratio of $USD traded by retail investors in a given ticker divided by total $USD traded by retail investors across all tickers.
• “Buy/Sell Sentiment” is a sentiment score, whereby the more positive the score, the greater the proportion of recent retail net buying.

With Retail Trading Activity Tracker, you can see the most heavily traded tickers each day, gauge the momentum of the crowd by analysing buy and sell sentiment and assess how current events impact what Main Street is buying and selling.

Top Market Reads

What the S&P's Record High Means for Investors

Martin Tillier

Airbnb Stock (NASDAQ:ABNB): Expanding Scale to Drive More Growth

Pre-market stock activity, upcoming market events, global markets, nasdaq watch, subscribe to nasdaq+ for full access.

Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.

Market News and Commentary

Prediction: This Will Be Nvidia's Next Big Announcement

15 minutes ago The Motley Fool

Where Will Alibaba Stock Be in 5 Years?

Why 1 Top ETF Could Be an Ultimate Long-Term Growth Investment

25 minutes ago The Motley Fool

Could Investing $10,000 in Solana Make You a Millionaire?

30 minutes ago The Motley Fool

A Big Week for Inflation and Economic Data… So, When Will the Fed Cut Rates?

1 day ago InvestorPlace

Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’

Phase 2 of the AI Boom Is Here – and One Company Is Going to Be the Next Trillio...

Berenberg Bank Initiates Coverage of Porvair (LSE:PRV) with Buy Recommendation

10 hours ago Fintel

Gold Prices Forecast: Will China Stimulus and Rate Cut Hopes Persist?

6 hours ago FX Empire

XRP News Today: Ripple Expansion Plans, Court Rulings, and Appeals

Bitcoin (BTC) News Today: BTC Stability as ETF Inflows Counter Fed Rate Cut Jitt...

7 hours ago FX Empire

Crude Oil News Today: Will Rate Cuts Lead to Increased Demand and Higher Prices?

8 hours ago FX Empire

Lessons for Investors from the Four Years Since the Pandemic Low

Mar 26, 2024 Martin Tillier

Today’s Children Could Make Trillions Less Over the Course of Their Life Due to ...

Aug 29, 2023 Chris Morris

#TradeTalks: How COVID-19 had a disproportionate impact on black small businesses.

#TradeTalks: How stay-at-home brands can seize the momentum they saw from the pandemic

Natural Gas News: Will Sellers Emerge at $2.686 to $2.867 Resistance?

5 hours ago FX Empire

How High Can the Gold Price Go? Mining Billionaires Share Big Predictions

1 day ago Investing News Network

Natural Gas Price Forecast: Bull Trend Continues Towards 2.68

1 day ago FX Empire

Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Gains Ground As China’s Industri...

Upside Risks Cast Shadow Over Oil Market Stability, Says World Bank

May 2, 2024 Hedder

The Chicken and Egg of Inflation and Commodity Prices

Apr 9, 2024 Martin Tillier

Inflation Warnings as Gold Continues to Climb

Apr 1, 2024 Nasdaq IR Intelligence

US crude oil production down in January due to severe weather, EIA says

Mar 29, 2024 Reuters

Analyst Upgrades:

Analyst downgrades:, actionable investing lists.

Dividend Aristocrats are companies that are part of the S&P 500 and have increased their dividends in each of the past 25 years. Learn about how to leverage these investments in your growth strategy.

Momentum investing is an approach that involves buying stocks that have gone up the most. Learn more about the stocks that make up this list.

Wide moat stocks typically have significant competitive advantages that allow them to fight off competition and maintain high profitability and returns on capital. Read more about the stocks that make up this list.

• Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return.

These symbols will be available throughout the site during your session.

Your symbols have been updated

Edit watchlist.

• Type a symbol or company name. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return.

Opt in to Smart Portfolio

Smart Portfolio is supported by our partner TipRanks. By connecting my portfolio to TipRanks Smart Portfolio I agree to their Terms of Use .

We use cookies to ensure best experience for you

We use cookies and other tracking technologies to improve your browsing experience on our site, show personalize content and targeted ads, analyze site traffic, and understand where our audience is coming from. You can also read our privacy policy , We use cookies to ensure the best experience for you on our website.

By choosing I accept, or by continuing being on the website, you consent to our use of Cookies and Terms & Conditions .

• Leaders Speak
• Brand Solutions
• Pharma Industry
• Smart wearables going to revolutionise the clinical research scenario, says expert

• Prathiba Raju ,
• ETHealthWorld
• Updated On May 14, 2024 at 07:34 PM IST

• By Prathiba Raju ,
• Published On May 14, 2024 at 11:32 AM IST

All Comments

By commenting, you agree to the Prohibited Content Policy

Find this Comment Offensive?

• Foul Language
• Inciting hatred against a certain community
• Out of Context / Spam

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis., download ethealthworld app.

• Get Realtime updates
• Save your favourite articles

• clinical research
• Health News
• revolutionise
• data collection
• clinical trials
• AI controlled
• drug testing
• Pharma Home